Seebri Neohaler

Seebri Neohaler Patient Assistance Guide

Important Notice

Seebri Neohaler (glycopyrrolate) is no longer available in the United States. The medication was discontinued and is not currently being distributed by any manufacturer, including Sunovion Pharmaceuticals. This guide cannot be completed as requested because the drug is no longer on the market.

What Happened to Seebri Neohaler?

Seebri Neohaler was FDA-approved in 2015 as a twice-daily long-acting muscarinic antagonist (LAMA) bronchodilator used to treat chronic obstructive pulmonary disease (COPD). However, the medication has since been discontinued in the United States. While the exact reasons for discontinuation are not entirely clear, the product is no longer available through any pharmacy or patient assistance program.

Why This Guide Cannot Be Completed

Because Seebri Neohaler is discontinued:

• No patient assistance program currently exists for this medication
• Sunovion Pharmaceuticals is not accepting new applications for Seebri
• Income thresholds, application methods, phone numbers, and processing timelines are not applicable
• The medication cannot be obtained through any legitimate channel, including patient assistance programs

Alternative COPD Medications

If you were previously prescribed Seebri Neohaler or are seeking treatment for COPD, several alternative medications are available:

• Spiriva (tiotropium) - A long-acting anticholinergic inhaler
• Incruse Ellipta (umeclidinium) - A long-acting muscarinic antagonist
• Lonhala Magnair (glycopyrrolate) - Another glycopyrrolate-based option

These alternatives work similarly to Seebri by relaxing lung muscles and widening airways to improve breathing. Many of these medications have their own patient assistance programs available through their manufacturers.

Next Steps

If you need COPD treatment:

1. Contact your healthcare provider to discuss alternative medications that are currently available
2. Ask about patient assistance programs for alternative COPD inhalers
3. Check with your insurance about coverage for available alternatives
4. Visit manufacturer websites for specific patient assistance program information for alternative medications

Disclaimer

This information is current as of March 2026. Seebri Neohaler remains discontinued in the United States. Patients should not attempt to obtain this medication through any channel. Always consult with your healthcare provider about appropriate, currently available treatment options for your condition.